Hudson-alpha Institute For Biotechnology is a 501(c)(3) organization based in Huntsville, Alabama, registered in 2005, with $52,208,987 in FY2024 revenue. CharityIndex grades it B+, and it directs about 73% of spending to programs.
Revenue (FY2024)
$52.2M
▼ 15.3% vs prior year
Science & Tech median: $288K
Expenses (FY2024)
$60.1M
Net assets
$179.0M
Employees
268
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Hudson-alpha Institute For Biotechnology: 73% to programs · $3 to raise $100 earns a B on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Hudson-alpha Institute For Biotechnology: 36 mo reserves · -15% margin earns a C+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Hudson-alpha Institute For Biotechnology: 5 of 6 checks met earns a A on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Hudson-alpha Institute For Biotechnology: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
The primary mission of the institute will be to use the increasingly powerful research tools being developed in the biotechnology area to better understand the causes of certain diseases and to apply the findings of such research to help develop new and more effective treatments for such diseases. the institute's charitable mission contemplates numerous other activities all of which are intended to help further biotech research in alabama.
Activities, programs and collaborations for the institute to accomplish its charitable objective of providing a variety of educational outreach programs.
Activities, programs and collaborations for the institute to accomplish its charitable objective of developing, providing and advancing genomic medicine programs.
Activities, programs and collaborations for the institue to accomplish its charitable objective of creating economic growth in biotechnology related fields
Revenue grew from $37.2M (FY2013) to $52.2M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
-15.2%
Spent more than it raised in the latest fiscal year.
Total assets
$205.8M
Total liabilities
$26.9M
Net assets
$179.0M
Salaries & benefits
$11.6M
19% of expenses
Board members
9
9 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $52,208,987▼15.3% | $60,147,672▼0.3% | $178,965,229▼5.8% | $205,847,270▼6.8% | 990 |
| 2023 | $61,674,062▲14.5% | $60,303,724▲12.1% | $189,931,612▲1.5% | $220,821,713▼2.4% | 990 |
| 2022 | $53,847,313▲18.8% | $53,817,844▼14.3% | $187,068,030▲5.9% | $226,249,482▲20.0% | 990 |
| 2021 | $45,340,795▼12.5% | $62,805,363▲9.1% | $176,628,244▼7.6% | $188,566,945▼10.8% | 990 |
| 2020 | $51,805,437▼62.9% | $57,579,622▼2.5% | $191,241,307▲2.4% | $211,512,056▲9.0% | 990 |
| 2019 | $139,619,021▲73.1% | $59,036,723▼17.7% | $186,713,985▲80.4% | $194,073,537▲57.1% | 990 |
| 2018 | $80,668,556▲57.3% | $71,732,125▲15.7% | $103,513,974▲9.3% | $123,524,115▲5.2% | 990 |
| 2017 | $51,277,870▼23.8% | $62,003,431▲14.2% | $94,736,896▼10.1% | $117,385,988▼2.9% | 990 |
| 2016 | $67,252,095▲77.3% | $54,276,217▲9.6% | $105,410,881▲12.4% | $120,912,858▲9.1% | 990 |
| 2015 | $37,939,241▲6.2% | $49,529,285▲29.3% | $93,758,566▼31.3% | $110,858,487▼24.4% | 990 |
| 2014 | $35,716,838▼4.1% | $38,292,273▲11.1% | $136,549,678▼3.2% | $146,654,167▼0.4% | 990 |
| 2013 | $37,241,351 | $34,469,983▲1.2% | $141,038,079▲5.9% | $147,263,141▲5.0% | 990 |
| 2012 | — | $34,049,089▼1.9% | $133,141,260▲0.2% | $140,221,297▲1.1% | 990 |
| 2011 | — | $34,700,452▲0.6% | $132,880,825▲1.0% | $138,674,189▼1.3% | 990 |
| 2010 | — | $34,505,373 | $131,604,109 | $140,525,594 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Richard Myers — $650,725 (1.08% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Richard Myers | Chief Scient | 40 | $650,725 |
| Neil Lamb | President | 40 | $361,240 |
| Jeremy Schmutz | Principal In | 40 | $324,422 |
| Carter Wells | Vp Econ Deve | 40 | $320,354 |
| Jane Grimwood | Principal In | 40 | $317,202 |
| Danny Windham | Coo | 40 | $267,609 |
| Gregory Cooper | Principal In | 40 | $242,778 |
| Chris Matl | Cfo | 40 | $220,417 |
| Sara Cooper | Principal In | 40 | $218,693 |
| Josh Clevenger | Principal In | 40 | $214,170 |
| Kelly M East | Vp Education | 40 | $207,349 |
| Gregg Tyree | Dir/operatio | 40 | $205,210 |
| Joseph S Newberry | Software Eng | 40 | $188,894 |
| Jerry W Jenkins | Genome Analy | 40 | $180,330 |
| Florencia Behn | Research Aff | 40 | $174,247 |
| Dave Flowers | Biologist | 40 | $171,921 |
| Kankshita Swaminathan | Faculty Inve | 40 | $171,869 |
| Alex E Harkess | Faculty Inve | 40 | $166,756 |
| Richard J Johnson | System Archi | 40 | $163,112 |
| Michael J Frizzell | Comp. Struct | 40 | $161,297 |
| Contractor | Services | Paid |
|---|---|---|
| Wshp Fc Holdings LLC | Sequencing | $6,896,624 |
| Gener8tor Mangement LLC | Consulting | $1,237,500 |
| Carl Zeiss Microscopy LLC | Science Equip | $747,612 |
| Edge Solutions LLC | It Services | $618,054 |
| Marsh & Mclennan Agency LLC | Insurance | $540,963 |
41 grants to Hudson-alpha Institute For Biotechnology totaling $14.5M, reported by foundations on their Schedule I filings — showing the 15 most recent.
Explore more
Data for Hudson-alpha Institute For Biotechnology (EIN 43-2059317) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.